PDF4PRO ⚡AMP

Modern search engine that looking for books and documents around the web

Example: marketing

Extravasation/Infiltration Management Chart

← Back to document page

JHH Extravasation/Infiltration Policy: procedures for compresses/antidotes: Compresses (**should not be used in neonates)Cold Compresses (**should not be used in neonates)HyaluronidasePhentolamineDexraz oxaneSodium ThiosulfateAcyclovir*XX * Vesicants are highlighted in this colorAllopurinolXAminophylline*XXAmiodar oneXAmphotericin BXArginine HCLXXArsenic TrioxideXXBleomycinX Infiltration Grading ScaleBusulfanXXGradeClinical CriteriaCalcium Chloride*XX0 No symptomsCalcium Gluconate*XX1 Skin blanchedCARBOplatinX With or without painCarmustineX Cool to touchCISplatin*XX Edema <1" in any directionCladribineXX Skin blanchedCyclophosphamideXX With or without

Docetaxel X € Moderate to severe pain DOPamine* X € Skin tight, leaking DOXorubicin X X € Skin discolored, bruised, swollen Doxycycline* X X € Deep pitting tissue edema Epinephrine* X € Gross edema >6" in any direction Erythromycin X € Circulatory impairment Esmolol X X € Blood product, irritant, or vesicant infiltration Etomidate ...

  Doxorubicin, Docetaxel

Download Extravasation/Infiltration Management Chart

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Spam in document Broken preview Other abuse

Documents from same domain

Pediatric Pharmacy Inpatient Care Programs

pedsrx.johnshopkins.edu

The Pediatric Pharmacy Inpatient Programs are managed by our Pediatric Clinical Pharmacy Specialists ... & Cardiology/Heart Transplant Cell: (609) 937 – 6202 1. Call Cell 2. CORUS ... inpatient anticoagulation requires pharmacists to complete a warfarin competency, followed by evaluation. ...

  Pediatric, Cardiology, Anticoagulation

Parenteral Nutrition Recommendations for Pediatric Patients

pedsrx.johnshopkins.edu

Jul 13, 2018 · July 13, 2018 . PN Additives Indications for Use Dosing Trace Elements All patients, unless direct hyperbilirubinemia or otherwise indicated. Auto defaults in EPIC to weight based dosing. You will need to modify dosing if hyperbilirubinemia (Dbili >2).

  Nutrition, Parenteral, Parenteral nutrition

Related documents

BC Cancer Extravasation Hazard Table

www.bccancer.bc.ca

BC Cancer Extravasation Hazard Table (Systemic Therapy Policy III-20) Developed: 1 November 2014 Revised: 1 December 2021 BC Cancer Extravasation Hazard Table

James Patient Education Handouts A-Z

healthsystem.osumc.edu

Docetaxel Doxorubicin Liposomal (Doxil) James Patient Education Handouts (A – Z) Click on the title to see the handout To narrow your search use “Ctrl + F” and enter a keyword . The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

  Doxorubicin, Docetaxel, Docetaxel doxorubicin

POTENTIAL IRRITANT MEDICATIONS

mi-hms.org

POTENTIAL IRRITANT MEDICATIONS * (Consider administration via central venous catheter – should not administer via Midline) *An irritant is an agent capable of producing discomfort or pain along the internal lumen of the vein (s 105 INS SOP …

PRINCIPLES OF CHEMOTHERAPY IN CANCER

oncologypro.esmo.org

Doxorubicin Doxorubicin Liposomal Epirubicin Idarubicin Mitomycin Mitoxantrone. MITOTIC SPINDLE AGENTS Docetaxel Paclitaxel Paclitaxel Albumin Cabazitaxel Vincristine Vinblastine Vinorelbine Mechanism of action: Bind to microtubular proteins, thus inhibit microtubule assembly resulting in dissolution of the

  Doxorubicin, Docetaxel, Doxorubicin doxorubicin

Reference ID: 3101735

www.accessdata.fda.gov

Docetaxel Injection in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node-positive breast cancer. 1.2 Non-Small Cell Lung Cancer . Docetaxel Injection as a single agent is indicated …

  Doxorubicin, Docetaxel

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

www.ema.europa.eu

patients receiving Herceptin therapy alone or in combination with paclitaxel or docetaxel, particularly following anthracycline (doxorubicin or epirubicin) containing chemotherapy. These may be moderate to severe and have been associated with death (see section 4.8). In addition, caution should be

  Doxorubicin, Docetaxel

Related search queries

Docetaxel Doxorubicin, Doxorubicin Doxorubicin, Docetaxel, Doxorubicin